Sight Sciences, Inc. (SGHT) Research

Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its product portfolio features the OMNI Surgical System, a therapeutic instrument utilized by eye surgeons to alleviate intraocular pressure in adult glaucoma patients. Another notable offering is the TearCare System, a wearable eyelid technology employed by ophthalmologists and optometrists for managing dry eye disease (DED). The company makes its products available across the United States, reaching hospitals, medical centers, and eye care professionals through its direct sales force and distribution partners. Founded in 2010, Sight Sciences' corporate operations are based in Menlo Park, California.

Market snapshot

Symbol
SGHT
Price
$5.28
Day change
+5.39%
Market cap
$287.3M
P/E ratio
-7.65x
52-week range
3.11-9.236
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 2 months
Analyst price target
$9.50

Peer companies

  • Cerus Corporation (CERS)
  • CVRx, Inc. (CVRX)
  • Lifecore Biomedical, Inc. (LFCR)
  • 908 Devices Inc. (MASS)
  • Owens & Minor, Inc. (OMI)
  • ProQR Therapeutics N.V. (PRQR)
  • Quanterix Corporation (QTRX)
  • Senseonics Holdings, Inc. (SENS)

Recent insider activity

  • Encrantz Staffan — P-Purchase (14100 shares) on 2026-06-10
  • Fountain Tamara — A-Award (28261 shares) on 2026-06-04
  • Encrantz Staffan — A-Award (28261 shares) on 2026-06-04
  • Burbach Gerhard F — A-Award (28261 shares) on 2026-06-04
  • Zurbay Donald — A-Award (28261 shares) on 2026-06-04

Open Sight Sciences, Inc. (SGHT) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.